Journals / Türk Üroloji Dergisi/Turkish Journal of Urology / 2009 / Cilt: 35 - Sayı: 2

Comparison between 5-day ciprofloxacin and single-dose levofloxacin in antibiotic prophylaxis for transrectal prostate biopsy

Transrektal prostat biyopsisi için antibiyotik profilaksisinde 5 günlük siprofloksasin ile tek doz levofloksasin tedavisinin karşılaştırılması

Pages
82–86
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Conclusion: Both single-dose levofloxacin and five-day ciprofloxacin regimens seem to be equally effective in the antibiotic prophylaxis for transrectal prostate biopsy, but levofloxacin offers the advantage of single-dose usage.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: The aim of this study was to compare the efficacy of single-dose 500 mg oral levofloxacin administration and five-day oral ciprofloxacin regimen in preventing infectious complications following transrectal prostate biopsy.
📊
Key Findings & Data:Materials and methods: The study included 142 patients (mean age 65±8 years; range 43 to 82 years) undergoing 12-core transrectal prostate biopsy.
💡
Conclusion & Impact:Conclusion: Both single-dose levofloxacin and five-day ciprofloxacin regimens seem to be equally effective in the antibiotic prophylaxis for transrectal prostate biopsy, but levofloxacin offers the advantage of single-dose usage.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Prostat neoplazmları · Geriyedönük çalışma · Ultrasonografi

Abstract

Objective: The aim of this study was to compare the efficacy of single-dose 500 mg oral levofloxacin administration and five-day oral ciprofloxacin regimen in preventing infectious complications following transrectal prostate biopsy. Materials and methods: The study included 142 patients (mean age 65±8 years; range 43 to 82 years) undergoing 12-core transrectal prostate biopsy. In 72 patients, a single-dose 500 mg levofloxacin was given orally 30-60 minutes before the procedure, while 70 patients received five-day, 500 mg oral ciprofloxacin given twice daily starting one day before the procedure. Urine samples were obtained for urine microscopy and culture just before the procedure and after the last dose of ciprofloxacin. The two groups were compared with respect to findings of urine microscopy and culture before and after the procedure, and complications. Results: There were no significant differences between the two groups with respect to age, PSA level, prostate volume, findings of urine microscopy and culture before and after the procedure, and the incidence of fever after the procedure (p>0.05). In the levofloxacin and ciprofloxacin groups, five (6.9%) and three (4.3%) patients had positive urine cultures before the procedure, and the incidences of new culture-positivity were 3% (n=2) and 6% (n=4) after the procedure, respectively. The most commonly isolated bacteria was Escherichia coli. Within-group comparisons of urine microscopy and culture showed no significant differences for both groups (p>0.05). None of the patients developed sepsis or severe procedure-related complications. Conclusion: Both single-dose levofloxacin and five-day ciprofloxacin regimens seem to be equally effective in the antibiotic prophylaxis for transrectal prostate biopsy, but levofloxacin offers the advantage of single-dose usage.

Özet

Amaç: Çalışmada, transrektal prostat biyopsisi sonrası enfeksiyöz komplikasyonları önlemede 500 mgr oral tek doz levofloksasin ile beş günlük oral siprofloksasin profilaksisinin etkinliği karşılaştırıldı. Gereç ve yöntem: Çalışmaya 12-kor prostat biyopsisi yapılan 142 hasta (ort. yaş 65±8; dağılım 43-82) alındı. Hastalar iki gruba ayrıldı. Bir gruba (n=72) işlemden 30-60 dk önce tek doz 500 mgr levofloksasin oral olarak verildi. Diğer gruba (n=70) ise işlemden bir gün önce başlamak üzere 500 mgr siprofloksasin beş gün süreyle, günlük iki dozda oral olarak verildi. İşlemden hemen önce ve son siprofloksasin dozundan sonra tüm hastalardan idrar mikroskopisi ve kültürü için idrar örneği alındı. İki grup, biyopsi öncesi ve sonrası idrar mikroskopisi ve idrar kültürü pozitifliği ile biyopsi sonrası komplikasyonlar açısından karşılaştırıldı. Bul¬gu¬lar: Yaş, PSA düzeyi, prostat hacmi, biyopsi öncesi ve sonrası idrar mikroskopisi ile idrar kültürü ve biyopsi sonrası ateş gelişimi açısından gruplar arasında anlamlı fark görülmedi (p>0.05). Levofloksasin ve siprofloksasin gruplarında biyopsi öncesinde idrar kültürü sırasıyla beş hastada (6.9%) ve üç hastada (4.3%) pozitif bulundu; geri kalan kültür-negatif hastalar içinde biyopsi sonrasında yeni kültür pozitifliği sırasıyla iki (3%) ve dört (%6) hastada görüldü. En sık görülen bakteri Escherichia coli idi. Gruplar içinde de biyopsi öncesi ve sonrası idrar mikroskopisi ve idrar kültürü sonuçları bakımından anlamlı fark saptanmadı (p>0.05). Hiçbir hastada sepsis veya işlemle ilgili ciddi komplikasyon gelişmedi. So¬nuç: Hem tek doz levofloksasin hem de beş günlük siprofloksasin rejimleri transrektal prostat biyopsi profilaksisinde etkili yöntemlerdir. Ayrıca, levofloksasinin tek doz olma avantajı vardır.

🔖

Cite This Article

ATMACA, A. F., ASİL, E., CANDA, A. E., ŞEREFOĞLU, E. C., ÇAĞLAYAN, A., BALBAY, M. D. (2009). Comparison between 5-day ciprofloxacin and single-dose levofloxacin in antibiotic prophylaxis for transrectal prostate biopsy. Türk Üroloji Dergisi/Turkish Journal of Urology, Cilt: 35 - Sayı: 2, 82–86. https://ajindex.com/articles/328149

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Matlaga BR, Eskew LA, McCullough DL. Prostate biopsy: indications and technique. J Urol 2003;169:12-9
  2. Ramey JR, Halpern EJ, Gomella LG. Ultrasonography and biopsy of the prostate. In: Wein AJ, Kavoussi LR, Novick AC, Partin AW, Peters CA, editors. Campbell-Walsh urology. 9th ed. Philadelphia: Saunders-Elsevier; 2007. p. 2883-95
  3. Djavan B, Margreiter M. Biopsy standards for detection of prostate cancer. World J Urol 2007;25:11-7
  4. Webb NR, Woo HH. Antibiotic prophylaxis for prostate biopsy. BJU Int 2002;89:824-8
  5. Alecsandru D, Gestoso I, Romero A, Martinez A, Garcia A, Lobo J, et al. E. coli multiresistant meningitis after transrectal prostate biopsy. ScientificWorldJournal 2006; 6:2323-6
  6. Shen ZJ, Chen SW, Wang H, Zhou XL, Zhao JP. Life-threatening meningitis resulting from transrectal prostate biopsy. Asian J Androl 2005;7:453-5
  7. Crundwell MC, Cooke PW, Wallace DM. Patients’ tolerance of transrectal ultrasound-guided prostatic biopsy: an audit of 104 cases. BJU Int 1999;83:792-5
  8. Kapoor DA, Klimberg IW, Malek GH, Wegenke JD, Cox CE, Patterson AL, et al. Single-dose oral ciprofloxacin versus placebo for prophylaxis during transrectal prostate biopsy. Urology 1998;52:552-8
  9. Shandera KC, Thibault GP, Deshon GE Jr. Efficacy of one dose fluoroquinolone before prostate biopsy. Urology 1998;52:641-3
  10. Cam K, Kayıkcı A, Akman Y, Erol A. Prospective assessment of the efficacy of single dose versus traditional 3-day antimicrobial prophylaxis in 12-core transrectal prostate biopsy. Int J Urol 2008;15:997-1001
  11. Burden HP, Ranasinghe W, Persad R. Antibiotics for transrectal ultrasonography-guided prostate biopsy: are we practising evidence-based medicine? BJU Int 2008;101:1202-4
  12. Yamamoto S, Ishitoya S, Segawa T, Kamoto T, Okumura K, Ogawa O. Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin. Int J Urol 2008;15:604-6
  13. Lindstedt S, Lindström U, Ljunggren E, Wullt B, Grabe M. Single-dose antibiotic prophylaxis in core prostate biopsy: Impact of timing and identification of risk factors. Eur Urol 2006;50:832-7
  14. Griffith BC, Morey AF, Ali-Khan MM, Canby-Hagino E, Foley JP, Rozanski TA. Single dose levofloxacin prophylaxis for prostate biopsy in patients at low risk. J Urol 2002;168:1021-3
  15. Feliciano J, Teper E, Ferrandino M, Macchia RJ, Blank W, Grunberger I, et al. The incidence of fluoroquinolone resistant infections after prostate biopsy-are fluoro